Close search filters
Changing filters will change the listed Success Criteria and Techniques
Category
Topic
Search results (343)
Article
As more gene therapies come to market, payers need expanded options to protect their plans
August 28, 2024
Newsroom
Evernorth Names Tony Colistra New President of MD Live, Evernorth Workplace Care
September 04, 2024
Report
COVID-19, the flu, RSV: Preparing for the 2024 fall and winter virus season
September 05, 2024
Newsroom
Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early May
September 05, 2024
Article
2024 Health Care in Focus: Key insights from the Evernorth Research Institute
September 24, 2024
Article
Providing a high level of customization and modularity to third-party administrators and health plans
September 16, 2024
Newsroom
As Demand for Virtual Health Care Surges, Evernorth Announces Acquisition of Long-Term Partner, MDLIVE
February 26, 2021
Transaction creates a convenient and connected care experience for consumers, rapidly expands Evernorth’s portfolio and delivers accelerated growth.
Article
How drugmakers exploit the patent system to delay competition and inflate prices
September 23, 2024
Enabling competition between therapeutic alternatives is crucial to lowering costs for PBMs’ clients and patients.